LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

LLY

783.6

-1.64%↓

JNJ

152.55

-0.11%↓

ABBV

186.51

-1.24%↓

NVO

68.55

+1.24%↑

UNH

305.58

+0.32%↑

Search

Champions Oncology Inc

Avatud

SektorTervishoid

7.23 7.59

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.73

Max

7.44

Põhinäitajad

By Trading Economics

Sissetulek

3.8M

4.5M

Müük

3.6M

17M

P/E

Sektori keskmine

17.911

50.291

Aktsiakasum

0.33

Kasumimarginaal

26.381

Töötajad

210

EBITDA

3.8M

4.9M

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

10. sept 2025

Turustatistika

By TradingEconomics

Turukapital

-23M

111M

Eelmine avamishind

-0.36

Eelmine sulgemishind

7.23

Uudiste sentiment

By Acuity

50%

50%

154 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Champions Oncology Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. dets 2024, 23:55 UTC

Kuumad aktsiad

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Võrdlus sarnastega

Hinnamuutus

Champions Oncology Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

0

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

5.77 / 7.61Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

154 / 380 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.